Entomophthoromycosis due to Basidiobolus is a known cause of subcutaneous zygomycosis. It occasionally causes invasive disease involving the gastrointestinal tract. We describe a case of proven subcutaneous entomophthoromycosis, with subsequent development of gastrointestinal basidiobolomycosis, in a 67 year old Singaporean Chinese male. He presented with a progressively enlarging left inguinal mass with intra-abdominal extension, causing compression of the ureters and hydronephroses. He underwent multiple biopsies to ascertain the cause of the mass. Workup for malignancy, bacteria, fungal, parasitic and tuberculous infections were negative. He developed worsening gastrointestinal distension a year from initial presentation. Imaging showed mucosal thickening extending from the descending colon to the rectum. Based on the clinical presentation, he was treated as for basidiobolomycosis. He responded poorly to treatment and passed away two months after initiation of therapy. With the help of our counterparts in India, we proved our clinical suspicion by polymerase chain reaction on tissue specimen. J Microbiol Infect Dis 2017; 7(3):151-155 
INTRODUCTION
Basidiobolus species are fungi that belong to the family Basidiobolaceae, of the order Entomophthorales. They are found in soil and decaying vegetable matter and as commensals in the gastrointestinal tract of amphibians, reptiles, fish and mammals [1] . Clinically, basidiobolomycosis causes chronic subcutaneous induration affecting the limbs and trunk. Rarely, it causes invasive disease involving the gastrointestinal tract or lungs. Minor trauma, local inoculation, and insect bites are the predominant modes of acquisition. Although widely prevalent in tropical and subtropical regions [2] , it is infrequently seen in a developed country like Singapore. We discuss a case of a patient with proven subcutaneous entomopthoromycosis, who subsequently developed gastrointestinal symptoms, due to presumptive gastrointestinal basidiobolomycosis (GIB). He underwent an open incisional biopsy of the mass in June 2013. Histology showed granulomatous inflammation with patchy areas of eosinophilic infiltrate. In addition, structures with a clear central space containing finely granular material and rimmed by a purplish-red outer lining were seen within the stroma and engulfed within giant cells (Figure 2 ). There was no evidence of malignancy. Figure1: PET CT showed hypermetabolic abnormal mucosal thickening extending from the descending colon to the rectum, in addition to the left inguinal mass. 
CASE

DISCUSSION
To our knowledge, this is the first case of entomopthoromycosis reported in Singapore. This is also the first case report worldwide of a patient with proven subcutaneous entomopthoromycosis who subsequently developed presumptive GIB.
Entomopthoromycosis is a chronic nonangioinvasive fungal infection affecting immunocompetent individuals. Infections are caused by conidiobolus or basidiobolus species, with the latter being the most common cause of the disease [3] . There are no specific risk factors. In a case series from Arizona, 3 out of 7 had diabetes mellitus [4] . Our patient also had a history of diabetes mellitus, albeit it being wellcontrolled. Classically, infection results in skin and subcutaneous masses of the thighs and buttocks. Visceral involvement is unusual and so far only basidiobolus has been isolated from specimens from visceral organs [3] .
GIB is not commonly reported in the literature and the total reported cases since 1964 till end 2014 were 52 cases worldwide [5] [6] [7] [8] [9] . Most cases were from areas with tropical and subtropical climates, mainly Africa and Asia. It is also an emerging infection in southwestern United States, with 19 cases reported through March 2012. 17 were residents of Arizona [5] .
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The most common presentation is abdominal pain. Other presenting symptoms are abdominal distension, constipation, abdominal mass, fever, weight loss, diarrhoea and vomiting. Classically, imaging show the presence of an intestinal mass, with the colon and the rectum being the most commonly affected. Non-specific bowel thickening, like that seen in our patient, is observed in about 25% of the patients on imaging studies [5] . Our patient had a PET/CT that showed hypermetabolic abnormal bowel thickening extending from the distal descending colon to the rectum and corresponding nodular mucosal thickening seen on colonoscopy. He had increasing abdominal distension, constipation and weight loss. These were suggestive of GIB. While histology did not show characteristic changes of entomopthoromycosis, this may be due to selective sampling during colonoscopy.
He also had possible dissemination to the urinary tract, similar to the patient described by Khan et al [10] . However, we did not send urine samples for fungal isolation and hence this is presumptive.
Diagnosis of GIB is difficult due to the nonspecific clinical manifestations. It mimics common conditions like malignancy, inflammatory bowel disease and intestinal tuberculosis, resulting in delayed diagnosis and significant morbidity. A high index of suspicion is crucial, more so in developed countries where the condition is exceedingly rare.
Culture from the affected tissue is the gold standard for diagnosis. Macroscopically, colonies are yellow gray with a waxy appearance and many radial folds. Microscopically, there is granulomatous inflammation with marked tissue eosinophilia and Splendore-Hoeppli phenomenon surrounding broad branching, pleomorphic and sparsely septated hyphae [2] . In culture negative cases, serology and DNA sequencing from tissues are alternative modalities.
The current experience of treating patients with gastrointestinal basidiobolomycosis is limited to only a few cases. Surgery, in combination with a prolonged course of Itraconazole, seems to be the optimal treatment [4, 5, 10] . Surgical excision was not performed for our patient as the mass was too large; Surgery would be too extensive, requiring pelvectomy, removal of bladder, bowel and rectum. Moreover, it was soft and friable and technically difficult to excise completely. Ketoconazole [11] , voriconazole [12] and posaconazole [13] have also been reported to be effective in a few cases. Amphotericin B was found to be active against only 50% of the isolates tested [1] and is less commonly used. Although KI has no known antifungal activity, it has been reported to be effective in treatment of subcutaneous basidiobolomycosis [14] and a case of retroperitoneal disease [15] .
Prognosis is usually favorable with subcutaneous disease alone. In contrast, GIB is an aggressive disease. Vikram et al reported a 20% mortality rate in the largest review to date of 44 patients with GIB, some of whom underwent surgical resection and received antifungal therapy [7] . Our patient had a fatal outcome. This may be due to advanced disease and that surgical resection of the mass was not feasible given its extent. He also had advanced illness with involvement of the gastrointestinal tract. In addition, the time from first presentation to initiation of therapy was a year.
In conclusion, basdiobolomycosis is an emerging disease, especially with increased international travel. Diagnosis is often delayed due to its nonspecific presentation and myriad of differentials. This case report highlights the importance of increased awareness, prompt diagnosis and treatment of this disease, which will then translate to less morbidity and mortality. 
